Relenza (zanamivir), a new INHALED antiviral for influenza

You'll hear a lot about Relenza (zanamivir), a new INHALED antiviral for influenza.

It's the first in a new class...neuraminidase inhibitors.

Blocking this enzyme reduces viral shedding...preventing the spread of the virus to uninfected cells.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote